Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Victor H. Gerbaudo, Ph.D.

Title
Institution
Department
Address
Phone
Fax
Profile Picture

Biography
education and training
BS, Health Sciences
PhD, Biological / Biomedical Sciences
Post-doctoral training , Nuclear Medicine
Post-doctoral training, Nuclear Oncology
MS, Health Care Administration
awards and honors
2000
Madame Curie Radiologic Science Lecturer
2001
Partners in Excellence Award in Leadership and Innovation
2003
Brigham Radiology Department Team Award
2004
Award of Merit, American Roentgen Ray Society
2004
One of 3 Best Papers of the Year Award, Society of Nuclear Medicine and Molecular Imaging
2007
Partners in Excellence Team Award: Cyclotron Project
2008
Partners in Excellence Team Award: Shapiro Cardiovascular Center Working Group
2008
Partners in Excellence Team Award: Electronic Signature Project
2012
Cum Laude Award, Radiological Society of North America
2013
One of 3 Best Papers of the Year Award, Society of Nuclear Medicine and Molecular Imaging
2014
Opening Plenary Speaker, World Federation of Nuclear Medicine & Biology Congress
2018
Professor S.K. Karma Oration Award, Association of Nuclear Medicine Physicians of India
2020
Invited Plenary Speaker, International Atomic Energy Agency
2021
Doctor Honoris Causa (Medicine), Universidad Maimónides, Argentina
2022
President-elect, New England Chapter, Society of Nuclear Medicine and Molecular Imaging

Overview
overview
Dr. Gerbaudo is a Senior Director in the Department of Radiology at Brigham and Women's Hospital. He leads the clinical and financial operations of Nuclear Medicine and Molecular Imaging, Non-invasive Cardiovascular Imaging, Cardiac Stress, Radiopharmacy, Cyclotron and Biomedical Imaging Core associated laboratories. In addition, he is the Senior Director of Research for the Department of Radiology at Brigham Health. Gerbaudo also serves as Director of Clinical Integration in the Department of Radiology at Brigham Health.

Dr. Gerbaudo is a nuclear oncology clinician scientist with a molecular pathology background and more than 20 years of experience in the field. His clinical, teaching and research efforts focus on the in-vivo qualitative and quantitative monitoring of tumor biology, imaging, and response to therapy with PET/CT.

Specific Academic Interests:
- Molecular biomarkers as predictors of clinical outcome in cancer patients
- Correlation between molecular biomarkers and medical imaging signatures
- PET Imaging-based phenotyping of thoracic malignancies
- Molecular imaging as a biomarker to non-invasively direct and monitor response to cancer therapy
keywords

Bibliographic
selected publications
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
  1. Katz SI, Straus CM, Roshkovan L, Blyth KG, Frauenfelder T, Gill RR, Lalezari F, Erasmus J, Nowak AK, Gerbaudo VH, Francis RJ, Armato SG. Considerations for Imaging of Malignant Pleural Mesothelioma: A Consensus Statement from the International Mesothelioma Interest Group. J Thorac Oncol. 2023 Mar; 18(3):278-298. PMID: 36549385.
    Citations:    Fields:    
  2. Gerbaudo VH, Latif MA. A Step Forward in PET-Based Quantitation of G3 Neuroendocrine Tumor Aggressiveness - The FDZ Score…. Acad Radiol. 2022 09; 29(9):1317-1319. PMID: 35365399.
    Citations:    Fields:    
  3. Zukotynski KA, Gaudet VC, Uribe CF, Chiam K, Bénard F, Gerbaudo VH. Clinical Applications of Artificial Intelligence in Positron Emission Tomography of Lung Cancer. PET Clin. 2022 Jan; 17(1):77-84. PMID: 34809872.
    Citations:    Fields:    Translation:Humans
  4. Zukotynski KA, Hasan OK, Lubanovic M, Gerbaudo VH. Update on Molecular Imaging and Precision Medicine in Lung Cancer. Radiol Clin North Am. 2021 Sep; 59(5):693-703. PMID: 34392913.
    Citations: 2     Fields:    Translation:Humans
  5. Shyn PB, Cubre AJ, Catalano PJ, Lee LK, Hyun H, Tuncali K, Seol JG, Levesque VM, Gerbaudo VH, Kapur T, Chao RT, Silverman SG. F-18 FDG perfusion PET: intraprocedural assessment of the liver tumor ablation margin. Abdom Radiol (NY). 2021 07; 46(7):3437-3447. PMID: 33606061.
    Citations: 1     Fields:    Translation:HumansCTClinical Trials
  6. Casadaban LC, Catalano PJ, Lee LK, Hyun H, Tuncali K, Gerbaudo VH, Shyn PB. Assessing ablation margins of FDG-avid liver tumors during PET/CT-guided thermal ablation procedures: a retrospective study. Eur J Nucl Med Mol Imaging. 2021 08; 48(9):2914-2924. PMID: 33559712.
    Citations: 2     Fields:    Translation:Humans
  7. Shashi KK, Madan R, Hammer MM, van Hedent S, Byrne SC, Schmidlin EJ, Mamon H, Hatabu H, Enzinger PC, Gerbaudo VH. Contribution of FDG-PET/CT to the management of esophageal cancer patients at multidisciplinary tumor board conferences. Eur J Radiol Open. 2020; 7:100291. PMID: 33304940; PMCID: PMC7711212.
    Citations: 2     
  8. Yan Z, Khorasani R, Levesque VM, Gerbaudo VH, Shyn PB. Liver tumor F-18 FDG-PET before and immediately after microwave ablation enables imaging and quantification of tumor tissue contraction. Eur J Nucl Med Mol Imaging. 2021 05; 48(5):1618-1625. PMID: 33175240.
    Citations: 1     Fields:    Translation:Humans
  9. Grossner T, Gotterbarm T, Gerbaudo VH, Haberkorn U, Spector M. 99mTc-Methyl-Diphosphonate Binding to Mineral Deposits in Cultures of Marrow-Derived Mesenchymal Stem Cells in Osteogenic Medium. Tissue Eng Part C Methods. 2019 01; 25(1):49-57. PMID: 30560717.
    Citations: 4     Fields:    Translation:HumansAnimalsCells
  10. Shyn PB, Casadaban LC, Sainani NI, Sadow CA, Bunch PM, Levesque VM, Kim CK, Gerbaudo VH, Silverman SG. Intraprocedural Ablation Margin Assessment by Using Ammonia Perfusion PET during FDG PET/CT-guided Liver Tumor Ablation: A Pilot Study. Radiology. 2018 Jul; 288(1):138-145. PMID: 29613843.
    Citations: 10     Fields:    Translation:Humans
  11. Gerbaudo VH, Killoran JH, Kim CK, Hornick JL, Nowak JA, Enzinger PC, Mamon HJ. Pilot study of serial FLT and FDG-PET/CT imaging to monitor response to neoadjuvant chemoradiotherapy of esophageal adenocarcinoma: correlation with histopathologic response. Ann Nucl Med. 2018 Apr; 32(3):165-174. PMID: 29332233.
    Citations: 5     Fields:    Translation:Humans
  12. Ramirez MA, Hyun H, Hainer J, Gerbaudo VH. Journal of Nuclear Medicine. Association between FDG-PET/CT imaging and length of hospital stay in an academic medical center . 2018; 59(suppl 1):519.
  13. Zukotynski K, Gerbaudo VH, Kim CK. SPECT/CT in Neoplastic Disease. In Kim CK and Zukotynski K CK, editors. SPECT and SPECT/CT: a clinical guide. Thieme Publishers. 2017. View Publication.
  14. Gerbaudo VH, Kim CK. PET Imaging-Based Phenotyping as a Predictive Biomarker of Response to Tyrosine Kinase Inhibitor Therapy in Non-small Cell Lung Cancer: Are We There Yet? Nucl Med Mol Imaging. 2017 Mar; 51(1):3-10. PMID: 28250852; PMCID: PMC5313468.
    Citations: 1     
  15. Zukotynski KA, Gerbaudo VH. Molecular Imaging and Precision Medicine in Lung Cancer. PET Clin. 2017 Jan; 12(1):53-62. PMID: 27863566.
    Citations: 5     Fields:    Translation:Humans
  16. Shim H, Joo J, Choi HJ, Hyun H, Gerbaudo VH, Kim CK. Lack of Increased FDG Uptake in the Lacrimal and Salivary Glands in Patients With Sarcoidosis and Potential Underlying Mechanism. Clin Nucl Med. 2016 Apr; 41(4):274-7. PMID: 26825201.
    Citations: 2     Fields:    Translation:Humans
  17. Choi HJ, Shim H, Hyun H, Gerbaudo VH, Kim CK. FDG PET/CT Appearance of Radiation Nephritis. Clin Nucl Med. 2016 Mar; 41(3):253-4. PMID: 26562578.
    Citations:    Fields:    Translation:HumansPHPublic Health
  18. Gerbaudo VH, Garcia CA . PET/CT of Lung Cancer. In Schoepf UJ & Meinel F. Multidetector-Row CT of the Thorax, 2nd ed. Springer International. 2016. View Publication.
  19. Barbone D, Follo C, Echeverry N, Gerbaudo VH, Klabatsa A, Bueno R, Felley-Bosco E, Broaddus VC. Autophagy Correlates with the Therapeutic Responsiveness of Malignant Pleural Mesothelioma in 3D Models. PLoS One. 2015; 10(8):e0134825. PMID: 26284517; PMCID: PMC4540424.
    Citations: 4     Fields:    Translation:HumansCells
  20. Zukotynski KA, Kim CK, Gerbaudo VH, Hainer J, Taplin ME, Kantoff P, den Abbeele AD, Seltzer S, Sweeney CJ. (18)F-FDG-PET/CT and (18)F-NaF-PET/CT in men with castrate-resistant prostate cancer. Am J Nucl Med Mol Imaging. 2015; 5(1):72-82. PMID: 25625029; PMCID: PMC4299771.
    Citations: 9     
  21. Horky LL, Gerbaudo VH, Zaitsev A, Plesniak W, Hainer J, Govindarajulu U, Kikinis R, Dietrich J. Systemic chemotherapy decreases brain glucose metabolism. Ann Clin Transl Neurol. 2014 Oct; 1(10):788-98. PMID: 25493270.
    Citations: 6     Fields:    
  22. Araki T, Sholl LM, Gerbaudo VH, Hatabu H, Nishino M. Thymic measurements in pathologically proven normal thymus and thymic hyperplasia: intraobserver and interobserver variabilities. Acad Radiol. 2014 Jun; 21(6):733-42. PMID: 24809315.
    Citations: 7     Fields:    Translation:Humans
  23. Sun Y, Gu X, Zhang E, Park MA, Pereira AM, Wang S, Morrison T, Li C, Blenis J, Gerbaudo VH, Henske EP, Yu JJ. Estradiol promotes pentose phosphate pathway addiction and cell survival via reactivation of Akt in mTORC1 hyperactive cells. Cell Death Dis. 2014 May 15; 5:e1231. PMID: 24832603; PMCID: PMC4047866.
    Citations: 24     Fields:    Translation:HumansAnimalsCells
  24. Araki T, Sholl LM, Gerbaudo VH, Hatabu H, Nishino M. Intrathymic cyst: clinical and radiological features in surgically resected cases. Clin Radiol. 2014 Jul; 69(7):732-8. PMID: 24824976.
    Citations: 17     Fields:    Translation:Humans
  25. Araki T, Sholl LM, Gerbaudo VH, Hatabu H, Nishino M. Imaging characteristics of pathologically proven thymic hyperplasia: identifying features that can differentiate true from lymphoid hyperplasia. AJR Am J Roentgenol. 2014 Mar; 202(3):471-8. PMID: 24555583; PMCID: PMC4020512.
    Citations: 15     Fields:    Translation:Humans
  26. Park M, Gerbaudo V, Hamberg L, Seaver K. Brain PET/CT Imaging on a Scanner with a Large Axial Field-Of-View. Medical Physics. 2014; 41(6):122-123.
  27. Wachsmann JW, Gerbaudo VH. Thorax: normal and benign pathologic patterns in FDG-PET/CT imaging. PET Clin. 2014 Apr; 9(2):147-68. PMID: 25030279.
    Citations: 1     Fields:    Translation:Humans
  28. Cervo M, Gerbaudo VH, Park MA, Moore SC. Quantitative simultaneous 111In/99mTc SPECT-CT of osteomyelitis. Med Phys. 2013 Aug; 40(8):082501. PMID: 23927346.
    Citations: 2     Fields:    Translation:Humans
  29. Wada K, Gerbaudo VH, Spector M. Effects of PDGF-BB and OP-1 on mesenchymal stem cells in a porous mineral block. Int J Periodontics Restorative Dent. 2013 Mar-Apr; 33(2):e72-8. PMID: 23484183.
    Citations: 1     Fields:    Translation:AnimalsCells
  30. Gerbaudo VH . Mesotelioma Maligno. In Soriano Castrejon A, Comin M & Garcia Vicente AM, editors. Medicina Nuclear en la Práctica Clínica, 2nd edition,. 2012. View Publication.
  31. Schleipman AR, Gerbaudo VH. Occupational radiation dosimetry assessment using an automated infusion device for positron-emitting radiotracers. J Nucl Med Technol. 2012 Dec; 40(4):244-8. PMID: 23024340.
    Citations: 2     Fields:    Translation:HumansPHPublic Health
  32. Donohoe KJ, Agrawal G, Frey KA, Gerbaudo VH, Mariani G, Nagel JS, Shulkin BL, Stabin MG, Stokes MK. SNM practice guideline for brain death scintigraphy 2.0. J Nucl Med Technol. 2012 Sep; 40(3):198-203. PMID: 22743146.
    Citations: 5     Fields:    Translation:Humans
  33. Ikuta I, Sodickson A, Wasser EJ, Warden GI, Gerbaudo VH, Khorasani R. Exposing exposure: enhancing patient safety through automated data mining of nuclear medicine reports for quality assurance and organ dose monitoring. Radiology. 2012 Aug; 264(2):406-13. PMID: 22627599; PMCID: PMC3401350.
    Citations: 4     Fields:    Translation:HumansPHPublic Health
  34. Gill RR, Richards WG, Yeap BY, Matsuoka S, Wolf AS, Gerbaudo VH, Bueno R, Sugarbaker DJ, Hatabu H. Epithelial malignant pleural mesothelioma after extrapleural pneumonectomy: stratification of survival with CT-derived tumor volume. AJR Am J Roentgenol. 2012 Feb; 198(2):359-63. PMID: 22268178.
    Citations: 24     Fields:    Translation:Humans
  35. Britz-Cunningham S, & Gerbaudo VH. Functional Anatomy of the FDG Image. In: Gerbaudo VH, editor. A Case-Based Approach to PET/CT in Oncology. Cambridge University Press. 2012. View Publication.
  36. Gerbaudo VH & Gill, R. Esophageal Cancer. In Gerbaudo VH , editor. A Case-Based Approach to PET/CT in Oncology. Cambridge University Press. 2012. View Publication.
  37. Gerbaudo VH, Editor. A Case-Based Approach to PET/CT in Oncology. Cambridge University Press. 2012. View Publication.
  38. Gerbaudo VH. Lung and Pleural Malignancies. In: Gerbaudo VH, editor. A Case-Based Approach to PET/CT in Oncology. Cambridge University Press. 2012. View Publication.
  39. Etchebehere E, Gerbaudo VH, Nuñez R, Obando A, Paez D, Sen I. . Guide on Clinical Standard Operating Procedures on the use of PET/CT: A Practical Approach for Use in Adult Oncology. International Atomic Energy Agency, Department of Nuclear Sciences and Applications, Division of Human Health, Nuclear Medicine Section; http://www-pub.iaea.org/MTCD/Publications/PDF/Pub1616_web.pdf . 2012. View Publication.
  40. Tatli, S, Gerbaudo VH, Silverman S. PET/CT Guided Interventions. In Gerbaudo VH , editor. A Case-Based Approach to PET/CT in Oncology. Cambridge University Press. 2012. View Publication.
  41. Killoran JH, Gerbaudo VH, Mamede M, Ionascu D, Park SJ, Berbeco R. Motion artifacts occurring at the lung/diaphragm interface using 4D CT attenuation correction of 4D PET scans. J Appl Clin Med Phys. 2011 Nov 15; 12(4):3502. PMID: 22089005.
    Citations: 10     Fields:    
  42. Nowak AK, Francis RJ, Katz SI, Gerbaudo VH. A Multimodality Imaging Review of Malignant Pleural Mesothelioma Response Assessment. PET Clin. 2011 Jul; 6(3):299-311. PMID: 27156725.
    Citations: 1     Fields:    
  43. Gerbaudo VH, Katz SI, Nowak AK, Francis RJ. Multimodality Imaging Review of Malignant Pleural Mesothelioma Diagnosis and Staging. PET Clin. 2011 Jul; 6(3):275-97. PMID: 27156724.
    Citations: 3     Fields:    
  44. Tatli S, Gerbaudo VH, Feeley CM, Shyn PB, Tuncali K, Silverman SG. PET/CT-guided percutaneous biopsy of abdominal masses: initial experience. J Vasc Interv Radiol. 2011 Apr; 22(4):507-14. PMID: 21367619.
    Citations: 24     Fields:    Translation:Humans
  45. Gerbaudo VH, Mamede M, Trotman-Dickenson B, Hatabu H, Sugarbaker DJ. FDG PET/CT patterns of treatment failure of malignant pleural mesothelioma: relationship to histologic type, treatment algorithm, and survival. Eur J Nucl Med Mol Imaging. 2011 May; 38(5):810-21. PMID: 21210110.
    Citations: 14     Fields:    Translation:Humans
  46. Gerbaudo VH and Jacobson F. PET/CT of Lung Cancer. In Van Den Abbeele, A.D. & Donahue K. Teaching Atlas of Nuclear Medicine. 2nd ed . Thieme Publishers. 2011. View Publication.
  47. Horky LL, Hsiao EM, Weiss SE, Drappatz J, Gerbaudo VH. Dual phase FDG-PET imaging of brain metastases provides superior assessment of recurrence versus post-treatment necrosis. J Neurooncol. 2011 May; 103(1):137-46. PMID: 20838854.
    Citations: 31     Fields:    Translation:Humans
  48. Tatli S, Gerbaudo VH, Mamede M, Tuncali K, Shyn PB, Silverman SG. Abdominal masses sampled at PET/CT-guided percutaneous biopsy: initial experience with registration of prior PET/CT images. Radiology. 2010 Jul; 256(1):305-11. PMID: 20574103.
    Citations: 25     Fields:    Translation:Humans
  49. Gerbaudo VH, Britz-Cunningham S. Primary lesions were more 18F-FDG avid in patients with distant spread than in those without extensive disease. Mol Imaging Biol. 2009 Nov-Dec; 11(6):487; author reply 488. PMID: 19845044.
    Citations:    Fields:    Translation:Humans
  50. Schleipman AR, Gallagher PW, Gerbaudo VH. Optimizing safety of selective internal radiation therapy (SIRT) of hepatic tumors with 90Y resin microspheres: a systematic approach to preparation and radiometric procedures. Health Phys. 2009 Feb; 96(2 Suppl):S16-21. PMID: 19125051.
    Citations:    Fields:    Translation:Humans
  51. Gill RR, Gerbaudo VH, Sugarbaker DJ, Hatabu H. Current trends in radiologic management of malignant pleural mesothelioma. Semin Thorac Cardiovasc Surg. 2009; 21(2):111-20. PMID: 19822282.
    Citations: 10     Fields:    Translation:Humans
  52. Ionascu D, Park SJ, Mamede M, Gerbaudo VH, Killoran J, Berbeco R. Quantifying the 4D PET/CT Volumetric Distortions: A 4D Dynamic Phantom Study Based on Pre-Recorded Patient Data. Medical Physics. 2009; 36(6):2467-2468.
  53. Britz-Cunningham SH, Millstine JW, Gerbaudo VH. Improved discrimination of benign and malignant lesions on FDG PET/CT, using comparative activity ratios to brain, basal ganglia, or cerebellum. Clin Nucl Med. 2008 Oct; 33(10):681-7. PMID: 18806567.
    Citations: 13     Fields:    Translation:Humans
  54. Park SJ, Ionascu D, Killoran J, Mamede M, Gerbaudo VH, Chin L, Berbeco R. Evaluation of the combined effects of target size, respiratory motion and background activity on 3D and 4D PET/CT images. Phys Med Biol. 2008 Jul 07; 53(13):3661-79. PMID: 18562782.
    Citations: 37     Fields:    Translation:Humans
  55. Gill RR, Gerbaudo VH, Jacobson FL, Trotman-Dickenson B, Matsuoka S, Hunsaker A, Sugarbaker DJ, Hatabu H. MR imaging of benign and malignant pleural disease. Magn Reson Imaging Clin N Am. 2008 May; 16(2):319-39, x. PMID: 18474335.
    Citations: 4     Fields:    Translation:Humans
  56. Park, SJ, Ionascu, T, Killoran J, Mamede, M, Gerbaudo, V, Chin, L, Berbeco, R. Automatic Segmentation of Static and Moving Target Volumes Using Respiratory Ungated (3D) and Gated (4D) PET/CT Images. Medical Physics. 2008; 36(6):2674.
  57. Ionascu D, Mamede M, Killoran J, Gerbaudo VH, Berbeco R. . Evaluation of Target Volume Reconstruction from 4D-PET/CT Imaging using a Dynamic Phantom and Patient Data. International Journal of Radiation Oncology Biology Physics. 2008; 72(1):10.1016/j.ijrobp.2008.06.229.
  58. Mamede M, El Fakhri G, Abreu-e-Lima P, Gandler W, Nosé V, Gerbaudo VH. Pre-operative estimation of esophageal tumor metabolic length in FDG-PET images with surgical pathology confirmation. Ann Nucl Med. 2007 Dec; 21(10):553-62. PMID: 18092131.
    Citations: 19     Fields:    Translation:Humans
  59. Zhu X, Park MA, Gerbaudo VH, Moore SC. Quantitative simultaneous In-111/Tc-99m planar imaging in a long-bone infection phantom. Phys Med Biol. 2007 Dec 21; 52(24):7353-65. PMID: 18065843.
    Citations: 2     Fields:    Translation:HumansCells
  60. Yamamuro M, Gerbaudo VH, Gill RR, Jacobson FL, Sugarbaker DJ, Hatabu H. Morphologic and functional imaging of malignant pleural mesothelioma. Eur J Radiol. 2007 Dec; 64(3):356-66. PMID: 17954021.
    Citations: 18     Fields:    Translation:Humans
  61. Gerbaudo VH, Julius B. Anatomo-metabolic characteristics of atelectasis in F-18 FDG-PET/CT imaging. Eur J Radiol. 2007 Dec; 64(3):401-5. PMID: 17870274.
    Citations: 5     Fields:    Translation:Humans
  62. Mamede M, Abreu-E-Lima P, Oliva MR, Nosé V, Mamon H, Gerbaudo VH. FDG-PET/CT tumor segmentation-derived indices of metabolic activity to assess response to neoadjuvant therapy and progression-free survival in esophageal cancer: correlation with histopathology results. Am J Clin Oncol. 2007 Aug; 30(4):377-88. PMID: 17762438.
    Citations: 25     Fields:    Translation:Humans
  63. Parysow O, Mollerach AM, Jager V, Racioppi S, San Roman J, Gerbaudo VH. Low-dose oral propranolol could reduce brown adipose tissue F-18 FDG uptake in patients undergoing PET scans. Clin Nucl Med. 2007 May; 32(5):351-7. PMID: 17452860.
    Citations: 46     Fields:    Translation:Humans
  64. Ionascu D, Killoran J, Mamede, M, Thomas S, Gerbaudo, V, Chin L, Berbeco, R. Medical Physics. Experimental evaluation of motion effects by integration of the 4DCT/4DPET hybrid GE discovery VCT scanner with the CIRS dynamic lung phantom. 2007; 34(6):10.1118/1.2760477.
  65. Gerbaudo VH. Functional Anatomy of Tumor Aggressiveness in Lung Cancer and Malignant Pleural Mesothelioma. Molecular Imaging and Biology. 2005; 7:86.
  66. Wang H, Gerbaudo VH, Hobbs LW, Spector M. Quantitation of osteoblast-like cell mineralization on tissue culture polystyrene and Ti-6Al-4V alloy disks by Tc-99m-MDP labeling and imaging in vitro. Bone. 2005 Jan; 36(1):84-92. PMID: 15664006.
    Citations: 5     Fields:    Translation:AnimalsCells
  67. Schleipman AR, Gerbaudo VH, Castronovo FP. Radiation disaster response: preparation and simulation experience at an academic medical center. J Nucl Med Technol. 2004 Mar; 32(1):22-7. PMID: 14990671.
    Citations: 3     Fields:    Translation:HumansPHPublic Health
  68. Moore, SC, Park M, El Fakhri G, Gerbaudo VH, Zimmerman RE. A General-Spectral Method for Improved Quantitative SPECT Imaging of In-111. Nuclear Science Symposium Conference Record, IEEE. 2004; 6:3682-3684.
  69. Rajadhyaksha CD, Parker JA, Barbaras L, Gerbaudo VH. Normal and Benign Pathologic Findings in 18-FDG-PET and PET/CT. Harvard Medical School Joint Program in Nuclear Medicine. 2004. View Publication.
  70. Gerbaudo VH, Britz-Cunningham S, Sugarbaker DJ, Treves ST. Metabolic significance of the pattern, intensity and kinetics of 18F-FDG uptake in malignant pleural mesothelioma. Thorax. 2003 Dec; 58(12):1077-82. PMID: 14645979.
    Citations: 8     Fields:    Translation:Humans
  71. Gerbaudo VH. 18F-FDG imaging of malignant pleural mesothelioma: scientiam impendere vero... Nucl Med Commun. 2003 Jun; 24(6):609-14. PMID: 12766595.
    Citations: 3     Fields:    Translation:Humans
  72. Donohoe KJ, Frey KA, Gerbaudo VH, Mariani G, Nagel JS, Shulkin B. Procedure guideline for brain death scintigraphy. J Nucl Med. 2003 May; 44(5):846-51. PMID: 12732688.
    Citations: 7     Fields:    Translation:Humans
  73. Gerbaudo VH, Sugarbaker DJ, Britz-Cunningham S, Di Carli MF, Mauceri C, Treves ST. Assessment of malignant pleural mesothelioma with (18)F-FDG dual-head gamma-camera coincidence imaging: comparison with histopathology. J Nucl Med. 2002 Sep; 43(9):1144-9. PMID: 12215551.
    Citations: 14     Fields:    Translation:Humans
  74. Di Carli MF, Gerbaudo VH, Singh TP, Treves ST. Cardiopulmonary Studies in Pediatric Nuclear Medicine . In: Sandler MP, Coleman RE and Patton JA, editors. Diagnostic Nuclear Medicine . 2002. View Publication.
  75. Di Carli M, Czernin J, Hoh CK, Gerbaudo VH, Brunken RC, Huang SC, Phelps ME, Schelbert HR. Relation among stenosis severity, myocardial blood flow, and flow reserve in patients with coronary artery disease. Circulation. 1995 Apr 01; 91(7):1944-51. PMID: 7895351.
    Citations: 92     Fields:    Translation:Humans
Local representatives can answer questions about the Profiles website or help with editing a profile or issues with profile data. For assistance with this profile: HMS/HSDM faculty should contact contactcatalyst.harvard.edu. For faculty or fellow appointment updates and changes, please ask your appointing department to contact HMS. For fellow personal and demographic information, contact HMS Human Resources at human_resourceshms.harvard.edu. For faculty personal and demographic information, contact HMS Office for Faculty Affairs at facappthms.harvard.edu.
Gerbaudo's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (258)
Explore
_
Co-Authors (41)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Physical Neighbors
_
© 2023 President and Fellows of Harvard College
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.